← Back to Search

Behavioral Intervention

iDECIDE Program for Substance Abuse in Students

N/A

Recruiting

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Currently enrolled in middle or high school

Be younger than 65 years old

Must not have

Gross cognitive impairment, for example due to florid psychosis, intellectual disability, developmental delay, or neurodegenerative disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory)

Awards & highlights

No Placebo-Only Group

Summary

This trial will test how a drug education program affects 300 school students who have violated their school's substance use policies. Outcomes will measure knowledge, attitudes, willingness to quit/reduce use, and substance use behavior.

Who is the study for?

This trial is for middle and high school students who recently broke their school's rules about drugs. They need a parent or guardian to agree if they're under 18, must be able to visit the study site 9 times over a year, have internet access for Zoom meetings, and can't be in daily heavy drug use or have had intense drug treatment before.

What is being tested?

The iDECIDE program aims to teach kids who've used substances better ways of thinking and acting instead of punishing them. About 300 students will either start this new program right away or wait (the control group) to see which helps more with their knowledge, attitudes, and actual substance use.

What are the potential side effects?

Since iDECIDE is an educational curriculum rather than a medication, it doesn't have medical side effects. However, participants may experience emotional discomfort when discussing substance use behaviors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a middle or high school student.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have severe cognitive issues like major psychosis or dementia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 1-month follow-up (primary) and 1-year follow-up (exploratory) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Frequency of Substance Use

Knowledge of Drug Effects and Brain Development

Perceived Harm of Substance Use

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: iDECIDEExperimental Treatment1 Intervention

Participants will... 1. Receive 4 weekly sessions of the iDECIDE drug curriculum. 2. Complete assessments and questionnaires, including self-reports of substance use and 4 urinalysis virtual visits. 3. Be video recorded for quality control.

Group II: Waitlist Control GroupActive Control1 Intervention

Participants will... 1. Not receive the iDECIDE curriculum during the weekly visits. They can choose to self-enroll in the iDECIDE curriculum at their one-month follow up visit. 2. Undergo symptom monitoring during the weekly visits. 3. Complete assessments and questionnaires, including self-reports of substance use and 4 urinalysis virtual visits.

0 / 2Eligibility criteria met